We serve Chemical Name:2-methoxy-N-(thiophen-2-ylmethyl)ethanamine CAS:852399-96-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-methoxy-N-(thiophen-2-ylmethyl)ethanamine
CAS.NO:852399-96-3
Synonyms:2-methoxy-N-(thiophen-2-ylmethyl)ethanamine
Molecular Formula:C8H13NOS
Molecular Weight:171.26000
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:231.4ºC at 760 mmHg
Density:1.07g/cm3
Index of Refraction:1.522
PSA:49.50000
Exact Mass:171.07200
LogP:1.87500
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-methoxy-N-(thiophen-2-ylmethyl)ethanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-methoxy-N-(thiophen-2-ylmethyl)ethanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-methoxy-N-(thiophen-2-ylmethyl)ethanamine Use and application,2-methoxy-N-(thiophen-2-ylmethyl)ethanamine technical grade,usp/ep/jp grade.
Related News: In his new role, Grégoire will ensure alignment between NOVA’s business strategy, operations and growth objectives, as well as leading the Modelling and Simulation (M&S) team as NOVA embarks on its next phase of expansion. 2-(3,5-dinitro-phenyl)-4-[3-(2-nitro-phenyl)-allylidene]-4H-oxazol-5-one manufacturers Events, Hatzalah of South Florida, and Ygrene and in partnership with the Shul of Bal Harbour we are able to continue this mission by providing first and last month rent as well as the security deposit for these families If this fund grows bigger, we will be able to continue to contribute funds directly for the rents.” Michael Capponi
“During this challenging time for the survivors, the uncertainty of not knowing where they will live exacerbates an already extremely painful and tragic situation. We are committed to the relocation efforts of all of the survivors through our partnership with Global Empowerment Mission.” Rabbi Zalman Lipskar, The Shul of Bal Harbour.
“We are devastated by the loss suffered by the victims, families of victims and the community at the hands of the Surfside tragedy. It is an honor to contribute to GEM’s Champlain Survivor Relocation Fund to provide safe and comfortable homes for survivors to help them get back on their feet, ” said Ygrene CEO, Jim Reinhart.
Baclofen is a muscle relaxant drug indicated for the treatment of muscle pain, spasms, and stiffness in people with multiple sclerosis, spinal cord injury, or disease.
This is Beximco Pharma’s ninth Abbreviated New Drug Application fully developed in-house and successfully approved for the US market since the Company’s oral solid dosage facility was approved by the US FDA in June 2015.
According to IQVIA audited market data, there are currently nine active players for Baclofen in the US market, which generated sales of more than $110 million in 2020.
Mr. Nazmul Hassan MP, Managing Director of Beximco Pharmaceuticals, said: We are pleased to have received FDA approval of Baclofen, a commonly prescribed medicine in the US, as we continue to leverage our core strengths in R&D and manufacturing to develop and deliver important generic products to patients. 1-[5-(5-Chloro-thiophen-2-yl)-isoxazol-3-ylmethyl]-5-nitro-1H-indole-2-carboxylic acid suppliers Zynteglo is a one-time treatment for a blood disorder known as beta thalassaemia in patients 12 years and older who require regular blood transfusions. GLUTAREDOXIN (Brucella melitensis strain 16M gene BMEI0184) vendor & factory.
“During this challenging time for the survivors, the uncertainty of not knowing where they will live exacerbates an already extremely painful and tragic situation. We are committed to the relocation efforts of all of the survivors through our partnership with Global Empowerment Mission.” Rabbi Zalman Lipskar, The Shul of Bal Harbour.
“We are devastated by the loss suffered by the victims, families of victims and the community at the hands of the Surfside tragedy. It is an honor to contribute to GEM’s Champlain Survivor Relocation Fund to provide safe and comfortable homes for survivors to help them get back on their feet, ” said Ygrene CEO, Jim Reinhart.
Baclofen is a muscle relaxant drug indicated for the treatment of muscle pain, spasms, and stiffness in people with multiple sclerosis, spinal cord injury, or disease.
This is Beximco Pharma’s ninth Abbreviated New Drug Application fully developed in-house and successfully approved for the US market since the Company’s oral solid dosage facility was approved by the US FDA in June 2015.
According to IQVIA audited market data, there are currently nine active players for Baclofen in the US market, which generated sales of more than $110 million in 2020.
Mr. Nazmul Hassan MP, Managing Director of Beximco Pharmaceuticals, said: We are pleased to have received FDA approval of Baclofen, a commonly prescribed medicine in the US, as we continue to leverage our core strengths in R&D and manufacturing to develop and deliver important generic products to patients. 1-[5-(5-Chloro-thiophen-2-yl)-isoxazol-3-ylmethyl]-5-nitro-1H-indole-2-carboxylic acid suppliers Zynteglo is a one-time treatment for a blood disorder known as beta thalassaemia in patients 12 years and older who require regular blood transfusions. GLUTAREDOXIN (Brucella melitensis strain 16M gene BMEI0184) vendor & factory.
